Why Strata Critical Medical, Inc. (SRTA) stock rose 17.6% on Wednesday, November 4, 2026

Strata Critical Medical, Inc. (SRTA) closed at $5.22, up 17.57% on Wednesday, November 4, 2026, on volume of 2,570,424 shares (2.8× its 3-month average); market value about $500.0M.

What happened: primary sources

Events Nexqual found for SRTA on Wednesday, November 4, 2026 or the trading day before (November 3, 2026):

• Nov 3, 2026: Reported Q3 2026 results: EPS −$0.09 vs consensus −$0.01 (miss), revenue $74.1M vs consensus $72.7M (beat). Guidance: The company reiterated its 2026 guidance of $285-295 million in revenue and $33-35 million in Adjusted EBITDA. source

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on SRTA

SRTA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: SRTA results, November 3, 2026. Other big moves that day: November 4, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:46 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:46 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt